Turing Pharmaceuticals: Fair Profit or Price Gouging in the Drug Industry? Harvard Case Solution & Analysis

Turing Pharmaceuticals: Fair Profit or Price Gouging in the Drug Industry? Case Solution

Abstract:

Turing's choice to raise the price of its anti-infection drug Daraprim, from $13.50 to $750 per dosage, is emblematic of the argument about the duties of pharmaceutical business and service more typically. The case asks: Do prescription executives have a duty to clients when setting drug rates, or are they beholden just to their investors? While set mostly in the United States, the case raises concerns of business social obligation and public policy for the international health care market and service more usually.

This is just an excerpt. This case is about  Responsibility

published: 29 May 2017

Turing Pharmaceuticals: Fair Profit or Price Gouging in the Drug Industry? Case Solution Other Similar Case Solutions like

Turing Pharmaceuticals: Fair Profit or Price Gouging in the Drug Industry?

Share This